Coherent Market Insights published a report, titled, the global meningococcal vaccines market size is estimated to grow from ...

. The global meningococcal vaccines market size is anticipated to grow nearly 2X, expanding from USD 4.53 Bn in 2025 to USD 9.05 Bn by 2032, recording a CAGR of 10.4% throughout the forecast ...

The concomitant administration of multiple vaccines at a single clinic visit reduces the number of required visits to healthcare providers and can improve compliance with vaccine recommendations ...

Kebbi — This week, Nigeria's Ministry of Health received over 1,000,000 pentavalent meningococcal conjugate vaccine (Men5CV) doses from the Gavi-funded global stockpile to combat the ...

The potential for herd immunity should be taken into consideration by policy makers deciding vaccine strategies. Similar herd effects are yet to be demonstrated for other meningococcal vaccines.

GSK’s 5-in-1 meningococcal vaccine Penmenvy receives positive recommendation from US Advisory Committee on Immunization Practices: London, UK Saturday, April 19, 2025, 13:00 Hrs ...

Since 2024, Gavi has supported Men5CV deployment for outbreak response, routine immunisation, and preventive mass campaigns in the meningitis belt. Nigeria became the first country to receive Men5CV ...

The Federal Ministry of Health and Social Welfare received over one million pentavalent meningococcal conjugate vaccine (Men5CV) doses from the Gavi-funded global stockpile this week to combat the ...

and Menveo (Meningococcal [Groups A, C, Y, and W-135] Oligosaccharide Diphtheria CRM197 Conjugate Vaccine). in February 2025, the US Food and Drug Administration approved GSK's MenABCWY vaccine ...